These epigenetic modifications provide a mechanistic basis for the persistent ferroptosis phenotype in COPD and highlight the therapeutic potential of targeting these pathways to restore Nrf2 function. The gene discussed is NFE2L2; the disease is chronic obstructive pulmonary disease.